Pralatrexate OverviewPralatrexate (brand name Folotyn) is an anti-cancer therapy. It is the first drug approved as a treatment for patients with relapsed or refractory peripheral T-cell lymphoma, or PTCL — a biologically diverse group of aggressive blood cancers that have a poor prognosis. Contents 1 Approval 2 Mechanism 3 Discovery 4 See also 5 References 6 External links Approval Folotyn was approved by the U.S. Food and Drug Administration...
Read more Pralatrexate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pralatrexate
Recent Pralatrexate Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 20mg/1ml, 40mg/2ml
- Solution: 20mg/ml (20mg/ml), 40mg/2ml (20mg/ml)
Other drugs which contain Pralatrexate or a similar ingredient: (1 result)
- FOLOTYN Pralatrexate